| Literature DB >> 25879706 |
Henrique Machado1,2, Eva C Sonnenschein3, Jette Melchiorsen4, Lone Gram5.
Abstract
BACKGROUND: Antibiotic resistance in bacteria spreads quickly, overtaking the pace at which new compounds are discovered and this emphasizes the immediate need to discover new compounds for control of infectious diseases. Terrestrial bacteria have for decades been investigated as a source of bioactive compounds leading to successful applications in pharmaceutical and biotech industries. Marine bacteria have so far not been exploited to the same extent; however, they are believed to harbor a multitude of novel bioactive chemistry. To explore this potential, genomes of 21 marine Alpha- and Gammaproteobacteria collected during the Galathea 3 expedition were sequenced and mined for natural product encoding gene clusters.Entities:
Mesh:
Substances:
Year: 2015 PMID: 25879706 PMCID: PMC4359443 DOI: 10.1186/s12864-015-1365-z
Source DB: PubMed Journal: BMC Genomics ISSN: 1471-2164 Impact factor: 3.969
Potential for production of bioactive secondary metabolites from 21 marine bacterial strains
|
|
|
|
|
|
|
|
| ||||
|---|---|---|---|---|---|---|---|---|---|---|---|
|
|
|
|
|
|
| ||||||
|
|
| 5.5 | yes | 12 | 0 | 3 | 19 | 1 | 0 | 1 | 0 |
|
|
| 5.4 | yes | 7 | 2 | 7 | 13 | 2 | 0 | 2 | 0 |
|
|
| 5.4 | yes | 7 | 2 | 7 | 13 | 2 | 0 | 2 | 0 |
|
|
| 6.2 | yes | 9 | 0 | 6 | 17 | 1 | 0 | 0 | 0 |
|
|
| 5.2 | yes | 6 | 1 | 4 | 12 | 1 | 0 | 1 | 0 |
|
|
| 4.0 | no | 2 | 0 | 5 | 0 | 0 | 0 | 0 | 0 |
|
|
| 5.3 | yes | 14 | 1 | 8 | 58 | 7 | 0 | 1 | 0 |
|
|
| 5.2 | yes | 10 | 1 | 7 | 30 | 2 | 0 | 2 | 0 |
|
|
| 4.4 | no | 2 | 0 | 5 | 0 | 0 | 0 | 0 | 0 |
|
|
| 4.1 | yes | 3 | 0 | 5 | 0 | 0 | 0 | 0 | 0 |
|
|
| 4.1 | yes | 3 | 0 | 5 | 0 | 0 | 0 | 0 | 0 |
|
|
| 6.1 | yes | 20 | 1 | 14 | 48 | 3 | 0 | 4 | 1 |
|
|
| 5.8 | yes | 17 | 2 | 12 | 56 | 3 | 0 | 2 | 1 |
|
|
| 5.2 | no | 5 | 0 | 7 | 0 | 0 | 0 | 0 | 0 |
|
|
| 5.4 | yes | 5 | 0 | 6 | 17 | 2 | 0 | 0 | 0 |
|
|
| 4.7 | yes | 5 | 1 | 3 | 3 | 0 | 0 | 0 | 0 |
|
|
| 3.6 | no | 5 | 1 | 3 | 3 | 0 | 0 | 0 | 0 |
|
|
| 4.0 | yes | 11 | 1 | 3 | 2 | 0 | 0 | 0 | 0 |
|
|
| 4.8 | yes | 8 | 1 | 4 | 1 | 0 | 0 | 0 | 0 |
|
|
| 4.6 | yes | 9 | 0 | 5 | 1 | 0 | 0 | 0 | 0 |
|
|
| 3.8 | yes | 9 + 1 | 0 | 4 | 1 | 1 | 0 | 0 | 0 |
Figure 1Previously known clusters identified in the studied marine bacteria, using genome mining. Andrimid gene cluster from V. coralliilyticus S2052 (A); Holomycin gene cluster from P. halotolerans S2753 (B).
Iron system in the studied strains, comprising and phenotypical results
|
|
|
|
|
|
|
| ||
|---|---|---|---|---|---|---|---|---|
|
|
|
|
|
| ||||
|
|
| - | - | 0 | + | 1 | 4 | 1 |
|
|
| (+) | - | 0 | - | 1** | 4*** | 1 |
|
|
| (+) | - | 0 | (+) | 1** | 4*** | 1 |
|
|
| - | - | 0 | - | 0 | 4*** | 1 |
|
|
| - | - | 0 | (+) | 1 | 3*** | 1 |
|
|
| + | + | 0 | + | 1** | 0 | 1 |
|
|
| - | - | 0 | + | 0 | 11*** | 1 |
|
|
| - | - | 0 | + | 0 | 5*** | 1 |
|
|
| - | - | 0 | + | 1 | 0 | 1 |
|
|
| - | - | 0 | + | 1 | 0 | 1 |
|
|
| - | - | 0 | - | 1 | 0 | 1 |
|
|
| + | + | 1 | (+) | 0 | 11*** | 1 |
|
|
| - | - | 0 | (+) | 0 | 9*** | 1 |
|
|
| - | - | 0 | (+) | 1 | 0 | 1 |
|
|
| - | - | 0 | + | 0 | 3*** | 1 |
|
|
| - | - | 0 | - | 0 | 1 | 1 |
|
|
| - | - | 1 | (+) | 0 | 1*** | 1 |
|
|
| + | + | 4 | - | 0 | 2 | 0 |
|
|
| - | - | 2 | (+) | 0 | 1*** | 1 |
|
|
| - | - | 2 | (+) | 0 | 1*** | 1 |
|
|
| - | + | 2 | + | 1* | 1 | 1 |
Cv: Chromobacterium violaceum, At: Agrobacterium tumefaciens, HSL: homoserine lactone, CAS: chrome-azurol-S, + : strong bioactivity, (+) : weak bioactivity, − : no bioactivity detected under the tested conditions, NRPS: including single NRPS clusters and NRPS fusion clusters (e.g. NRPS-bacteriocin, NRPS-ectoine). *Located on a plasmid; **Cluster identified as a siderophore – ectoine cluster; ***At least one NRPS is in proximity to siderophore-associated genes (tonB-dependent receptor etc.).
Figure 2Analysis of the Fur sequences of the marine bacterial strains used. Predicted Fur protein sequence alignment (A); Phylogenetic neighbor joining tree using Jukes-Cantor protein distance measurement method (B).
Chitinolytic systems in the studied strains, comprising and phenotypic results
|
|
|
|
| ||
|---|---|---|---|---|---|
|
|
|
| |||
|
|
| +++ | 3 | 1 | 1 |
|
|
| ++ | 9 | 1 | 2 |
|
|
| ++ | 9 | 1 | 2 |
|
|
| + | 8 | 2 | 0 |
|
|
| ++ | 7 | 1 | 0 |
|
|
| ++ | 3 | 1 | 1 |
|
|
| ++ | 4 | 1 | 0 |
|
|
| +++ | 4 | 0 | 0 |
|
|
| - | 0 | 0 | 0 |
|
|
| ++ | 3 | 0 | 1 |
|
|
| ++ | 3 | 0 | 1 |
|
|
| + | 10 | 0 | 0 |
|
|
| + | 7 | 0 | 0 |
|
|
| - | 0 | 0 | 0 |
|
|
| - | 0 | 0 | 0 |
|
|
| - | 0 | 0 | 1 |
|
|
| - | 0 | 0 | 0 |
|
|
| - | 0 | 0 | 0 |
|
|
| - | 0 | 1 | 0 |
|
|
| - | 0 | 1 | 0 |
|
|
| - | 0 | 0 | 0 |
ChiS: chitin catabolic cascade sensor histidine kinase, CBP: chitin binding proteins. - : no chitinase activity detected, + : low chitinase activity, ++ : medium chitinase activity, +++ : strong chitinase activity.